Gridsum November 27th | zhejiang hisoar pharmaceutical (002099.SZ) stated in recent investor relations activities that there is currently no sign of a recovery trend in the dye industry cycle. The company's dye sector saw a slight increase in sales volume in the first three quarters compared to the same period last year. The company is actively expanding into emerging areas such as digital inkjet printing, high-performance dye pigments, liquid crystals, etc., to promote the high-quality upgrade of the company's industrial chain and enhance the company's industry competitiveness.
海翔药业(002099.SZ)：公司染料板块1-3季度销量较去年同比略有提升
Zhejiang hisoar pharmaceutical (002099.SZ): The company's dye sector sales in the first to third quarters have slightly increased compared to last year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated